Yunnan Fangsheng Ronghe Pharmaceutical

Yunnan Fangsheng Ronghe Pharmaceutical is a Chinese pharmaceutical company primarily focused on the research, development, and manufacturing of chemical drugs and traditional Chinese medicine. As a subsidiary of Hunan Fangsheng Pharmaceutical, the company leverages a broad industrial base in Yunnan to produce treatments for chronic conditions, including cardiovascular and cerebrovascular diseases. Their portfolio includes a mix of established generic products and innovative pipeline candidates targeting metabolic disorders such as type 2 diabetes. The company operates modern manufacturing facilities that adhere to GMP standards, ensuring high-quality production for the domestic Chinese market. Yunnan Fangsheng Ronghe plays a key role in the parent group's strategy to integrate regional resources for pharmaceutical innovation and supply chain efficiency.